However, the VLDL reduction resulted only partially, not reaching the level observed in the CTR indicating that the abnormal lipids mobilization induced by the HER2-positive BC may require much more time for its normalization, thus, indicating that cancer may strongly modify the host metabolism far away from its homeostasis status. The gene discussed is ERBB2; the disease is breast cancer.